CYPRESS CAPITAL GROUP Abbott Laboratories Transaction History

CYPRESS CAPITAL GROUP portfolio value:

$9.12M
portfolio value

CYPRESS CAPITAL GROUP quarter portfolio value change:

-10.94%
quarter

Abbott Laboratories 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -6.40% -6.44K shares -1.82M $96.76 94.28K
Q2 2022 share Decrease -6.55% -7.06K shares -1.81M $108.65 100.73K
Q1 2022 share Increase 0.00% 107.79K shares 12.75M $118.36 107.79K
Q4 2021 share Decrease -100.00% -104.98K shares -12.40M $141 0
Q3 2021 share Increase +0.49% 509 shares 290K $117.68 104.98K
Q2 2021 share Decrease -0.89% -938 shares -520K $115.05 104.47K
Q1 2021 share Decrease -0.58% -615 shares 1.02M $118.49 105.41K
Q4 2020 share Increase +1.40% 1.46K shares 229K $107.81 106.02K
Q3 2020 share Increase +0.27% 281 shares 1.84M $106.81 104.56K
Q2 2020 share Decrease -2.93% -3.14K shares 1.05M $89.39 104.28K
Q1 2020 share Decrease -1.45% -1.57K shares -991K $76.84 107.43K
Q4 2019 share Decrease -1.10% -1.20K shares 247K $84.23 109.01K
Q3 2019 share Decrease -1.04% -1.15K shares -144K $80.81 110.22K
Q2 2019 share Decrease -0.14% -155 shares 450K $80.92 111.37K
Q1 2019 share Decrease -1.70% -1.92K shares 710K $76.6 111.53K
Q4 2018 share Increase +1.81% 2.01K shares 31K $68.98 113.45K
Q3 2018 share Increase +2.85% 3.08K shares 1.56M $69.69 111.44K
Q2 2018 share Increase +45.07% 33.66K shares 2.13M $57.68 108.35K
Q1 2018 share Decrease -1.13% -852 shares 164K $56.4 74.69K
Q4 2017 share Decrease -4.42% -3.49K shares 94K $53.46 75.54K
Q3 2017 share 0.00% 0 shares 375K $49.74 79.03K
Q2 2017 share Increase +10.79% 7.7K shares 674K $45.07 79.03K
Q1 2017 share Decrease -1.23% -892 shares 394K $40.93 71.33K
Q4 2016 share Increase +2.40% 1.69K shares -209K $35.17 72.22K
Q3 2016 share Decrease -2.32% -1.67K shares 145K $38.48 70.53K
Q2 2016 share Decrease -5.47% -4.17K shares -357K $35.55 72.20K
Q1 2016 share Decrease -39.86% -50.62K shares -2.50M $37.6 76.38K